Carisma Therapeutics Inc. Annual Income Tax Expense (Benefit) in USD from 2014 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Carisma Therapeutics Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2014 to 2022.
  • Carisma Therapeutics Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $0.000, a 100% decline year-over-year.
  • Carisma Therapeutics Inc. annual Income Tax Expense (Benefit) for 2022 was -$3.88M, a 53.2% increase from 2021.
  • Carisma Therapeutics Inc. annual Income Tax Expense (Benefit) for 2021 was -$8.27M, a 673% decline from 2020.
  • Carisma Therapeutics Inc. annual Income Tax Expense (Benefit) for 2020 was $1.45M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$3.88M +$4.4M +53.2% Jan 1, 2022 Dec 31, 2022 10-K 2023-02-28
2021 -$8.27M -$9.72M -673% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-28
2020 $1.45M +$1.45M Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $0 $0 Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $0 $0 Jan 1, 2018 Dec 31, 2018 10-K 2021-03-15
2017 $0 -$5K -100% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-01
2016 $5K +$5K Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 $0 $0 Jan 1, 2015 Dec 31, 2015 10-K 2018-04-02
2014 $0 Jan 1, 2014 Dec 31, 2014 10-K 2017-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.